Zevacor Molecular is a subsidiary of Illinois Health and Science (IHS), a non-profit healthcare system that specializes in enhancing patient care through strategic investments in healthcare-related opportunities.
Zevacor Molecular is a U.S. healthcare firm that develops, manufactures and distributes PET and SPECT radiopharmaceuticals and associated educational services used in nuclear medicine. Established in 2012 and dedicated to providing medical isotopes to support the diagnosis and treatment of critical illnesses, Zevacor is finalizing the construction of a new 70 MeV cyclotron and multiple synthesis and processing units for production and distribution of a broad range of clinical and research radioisotopes at its Noblesville, IN headquarters.
Zevacor Molecular is an Equal Opportunity / Affirmative Action employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability, protected veteran status, or other characteristic protected by law.